ACP
RARX

Acuta Capital Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Acuta Capital Partners’s Portfolio RARX Stock Details RARX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
2019
Q3 		$1.3M Buy
2018
Q2 		– Sell
2018
Q1 		$1.43M Buy
2017
Q4 		– Sell
2017
Q3 		$1.04M Sell
2017
Q2 		$7M Buy
2017
Q1 		$5.28M Sell
2016
Q4 		$5.74M Buy